DTL
RAPT

Dynamic Technology Lab’s RAPT Therapeutics RAPT Stock Holding History

Dynamic Technology Lab’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,735
Closed -$260K – 1251
2023
Q2 		$260K Buy
+1,735
New +$270K 0.03% 750
2021
Q4 		– Sell
-1,200
Closed -$298K – 1427
2021
Q3 		$298K Buy
+1,200
New +$317K 0.04% 758

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dynamic Technology Lab's RAPT Position: Q3 2023 in Review

Dynamic Technology Lab sold out of RAPT Therapeutics (RAPT) in Q3 2023, closing a stake of 1,735 shares — an estimated $260K sold.

Dynamic Technology Lab first reported a position in RAPT in Q3 2021 and held it in 2 quarters. The position peaked at $298K in Q3 2021. 96 funds tracked by Wall St. Rank hold RAPT as of Q3 2023.

  • Dynamic Technology Lab reported no remaining RAPT Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 1,735 RAPT Therapeutics shares in Q3 2023, an estimated $260K.
  • Dynamic Technology Lab first reported a position in RAPT Therapeutics in Q3 2021 and held it in 2 quarters.
  • Dynamic Technology Lab's RAPT Therapeutics position peaked at $298K in Q3 2021.
  • 96 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q3 2023.

Based on Dynamic Technology Lab's 13F filing for Q3 2023, filed 14 Nov 2023.